| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 1999;118:715-725
© 1999 Mosby, Inc.
CARDIOTHORACIC TRANSPLANTATION |
From the Division of Cardiovascular Surgery and The Center for Cardiovascular Research, Toronto General Hospital, University Health Network, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
Address for reprints: Ren-Ke Li, MD, PhD, Toronto Hospital– General Division, CCRW 1-815, 101 College St, Toronto, Ontario, Canada, M5G 2C4.
Objective: We have previously reported that fetal cardiomyocyte transplantation into myocardial scar improves heart function. The mechanism by which this occurs, however, has not been elucidated. To investigate possible mechanisms by which cell transplantation may improve heart function, we compared cardiac function after transplantation of 3 different fetal cell types: cardiomyocytes, smooth muscle cells (nonstriated muscle cells), and fibroblasts (noncontractile cells).
Methods: A left ventricular scar was created by cryoinjury in adult rats. Four weeks after injury, cultured fetal ventricular cardiomyocytes (n = 13), enteric smooth muscle cells (n = 10), skin fibroblasts (n = 10), or culture medium (control, n = 15 total) were injected into the myocardial scar. All rats received cyclosporine A (INN: ciclosporin). Four weeks after transplantation, left ventricular function was evaluated in a Langendorff preparation.
Results: The implanted cells were identified histologically. All transplanted cell types formed tissue within the myocardial scar. At an end-diastolic volume of 0.2 mL, developed pressures in cardiomyocytes group were significantly greater than smooth muscle cells and skin fibroblasts groups (cardiomyocytes, 134% ± 22% of control; smooth muscle cells, 108% ± 14% of control; skin fibroblasts, 106% ± 17% of control; P = .0001), as were +dP/dtmax (cardiomyocytes, 119% ± 37% of control; smooth muscle cells, 98% ± 18% of control; skin fibroblasts, 92% ± 11% of control; P = .0001) and –dP/dtmax (cardiomyocytes, 126% ± 29% of control; smooth muscle cells, 108% ± 19% of control; skin fibroblasts, 99% ± 16% control; P = .0001).
Conclusions: Fetal cardiomyocytes transplanted into myocardial scar provided greater contractility and relaxation than fetal smooth muscle cells or fetal fibroblasts. The contractile and elastic properties of transplanted cells determine the degree of improvement in ventricular function achievable with cell transplantation.
This article has been cited by other articles:
|
|
 |
|
  H. Hata, G. Matsumiya, S. Miyagawa, H. Kondoh, N. Kawaguchi, N. Matsuura, T. Shimizu, T. Okano, H. Matsuda, and Y. Sawa Grafted skeletal myoblast sheets attenuate myocardial remodeling in pacing-induced canine heart failure model J. Thorac. Cardiovasc. Surg., October 1, 2006; 132(4): 918 - 924. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. W.M. Fedak, P. E. Szmitko, R. D. Weisel, S. M. Altamentova, N. Nili, N. Ohno, S. Verma, S. Fazel, B. H. Strauss, and R.-K. Li Cell transplantation preserves matrix homeostasis: A novel paracrine mechanism J. Thorac. Cardiovasc. Surg., November 1, 2005; 130(5): 1430 - 1439. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Schuh, S. Breuer, R. Al Dashti, N. Sulemanjee, P. Hanrath, C. Weber, B. F. Uretsky, and E. R. Schwarz Administration of Vascular Endothelial Growth Factor Adjunctive to Fetal Cardiomyocyte Transplantation and Improvement of Cardiac Function in the Rat Model Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2005; 10(1): 55 - 66. [Abstract] [PDF]
|
|
|
|
 |
|
 K. L. Christman, A. J. Vardanian, Q. Fang, R. E. Sievers, H. H. Fok, and R. J. Lee Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium J. Am. Coll. Cardiol., August 4, 2004; 44(3): 654 - 660. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.H. Grinnemo, A. Mansson, G. Dellgren, D. Klingberg, E. Wardell, V. Drvota, C. Tammik, J. Holgersson, O. Ringden, C. Sylven, et al. Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium J. Thorac. Cardiovasc. Surg., May 1, 2004; 127(5): 1293 - 1300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Retuerto, P. Schalch, G. Patejunas, J. Carbray, N. Liu, K. Esser, R. G. Crystal, and T. K. Rosengart Angiogenic pretreatment improves the efficacy of cellular cardiomyoplasty performed with fetal cardiomyocyte implantation J. Thorac. Cardiovasc. Surg., April 1, 2004; 127(4): 1041 - 1050. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Fujii, T. M. Yau, R. D. Weisel, N. Ohno, D. A. G. Mickle, N. Shiono, T. Ozawa, K. Matsubayashi, and R.-K. Li Cell transplantation to prevent heart failure: a comparison of cell types Ann. Thorac. Surg., December 1, 2003; 76(6): 2062 - 2070. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. N. Olson and M. D. Schneider Sizing up the heart: development redux in disease Genes & Dev., August 15, 2003; 17(16): 1937 - 1956. [Full Text] [PDF]
|
|
|
|
 |
|
 G. H.L. Tang, P. W.M. Fedak, T. M. Yau, R. D. Weisel, A. Kulik, D. A.G. Mickle, and R.-K. Li Cell transplantation to improve ventricular function in the failing heart Eur. J. Cardiothorac. Surg., June 1, 2003; 23(6): 907 - 916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Fukuhara, S. Tomita, S. Yamashiro, T. Morisaki, C. Yutani, S. Kitamura, and T. Nakatani Direct cell-cell interaction of cardiomyocytes is key for bone marrow stromal cells to go into cardiac lineage in vitro J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1470 - 1480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Menasche Cell transplantation in myocardium Ann. Thorac. Surg., June 1, 2003; 75(90060): S20 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Dowell, M. Rubart, K. B.S. Pasumarthi, M. H. Soonpaa, and L. J. Field Myocyte and myogenic stem cell transplantation in the heart Cardiovasc Res, May 1, 2003; 58(2): 336 - 350. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Reffelmann and R. A. Kloner Cellular cardiomyoplasty--cardiomyocytes, skeletal myoblasts, or stem cells for regenerating myocardium and treatment of heart failure? Cardiovasc Res, May 1, 2003; 58(2): 358 - 368. [Full Text] [PDF]
|
|
|
|
|
|
B. Chazaud, L. Hittinger, C. Sonnet, S. Champagne, P. Le Corvoisier, N. Benhaiem-Sigaux, T. Unterseeh, J. Su, P. Merlet, A. Rahmouni, et al. Endoventricular porcine autologous myoblast transplantation can be successfully achieved with minor mechanical cell damage Cardiovasc Res, May 1, 2003; 58(2): 444 - 450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Al Attar, C. Carrion, S. Ghostine, I. Garcin, J.-T. Vilquin, A. A. Hagege, and P. Menasche Long-term (1 year) functional and histological results of autologous skeletal muscle cells transplantation in rat Cardiovasc Res, April 1, 2003; 58(1): 142 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. O. Al-Radi, V. Rao, R.-k. Li, T. Yau, and R. D. Weisel Cardiac cell transplantation: closer to bedside Ann. Thorac. Surg., February 1, 2003; 75(2): S674 - 677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Yau, S. Tomita, R. D. Weisel, Z.-Q. Jia, L. C. Tumiati, D. A.G. Mickle, and R.-K. Li Beneficial effect of autologous cell transplantation on infarcted heart function: comparison between bone marrow stromal cells and heart cells Ann. Thorac. Surg., January 1, 2003; 75(1): 169 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ruel, R. A. Kelly, and F. W. Sellke Therapeutic Angiogenesis, Transmyocardial Laser Revascularization, and Cell Therapy Card. Surg. Adult, January 1, 2003; 2(2003): 715 - 750. [Full Text]
|
|
|
|
 |
|
 S. Etzion, I. M. Barbash, M. S. Feinberg, P. Zarin, L. Miller, E. Guetta, R. Holbova, R. A. Kloner, L. H. Kedes, and J. Leor Cellular Cardiomyoplasty of Cardiac Fibroblasts by Adenoviral Delivery of MyoD Ex Vivo: An Unlimited Source of Cells for Myocardial Repair Circulation, September 24, 2002; 106(12_suppl_1): I-125 - I-130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Sakakibara, K. Tambara, F. Lu, T. Nishina, G. Sakaguchi, N. Nagaya, K. Nishimura, R.-K. Li, R. D. Weisel, and M. Komeda Combined Procedure of Surgical Repair and Cell Transplantation for Left Ventricular Aneurysm: An Experimental Study Circulation, September 24, 2002; 106(12_suppl_1): I-193 - I-197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Sakakibara, K. Tambara, F. Lu, T. Nishina, N. Nagaya, K. Nishimura, and M. Komeda Cardiomyocyte transplantation does not reverse cardiac remodeling in rats with chronic myocardial infarction Ann. Thorac. Surg., July 1, 2002; 74(1): 25 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Sakakibara, K. Nishimura, K. Tambara, M. Yamamoto, F. Lu, Y. Tabata, and M. Komeda Prevascularization with gelatin microspheres containing basic fibroblast growth factor enhances the benefits of cardiomyocyte transplantation J. Thorac. Cardiovasc. Surg., July 1, 2002; 124(1): 50 - 56. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Roell, Z. J. Lu, W. Bloch, S. Siedner, K. Tiemann, Y. Xia, E. Stoecker, M. Fleischmann, H. Bohlen, R. Stehle, et al. Cellular Cardiomyoplasty Improves Survival After Myocardial Injury Circulation, May 21, 2002; 105(20): 2435 - 2441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A Thompson and S. N Oesterle Biointerventional cardiology: the future interface of interventional cardiovascular medicine and bioengineering Vascular Medicine, May 1, 2002; 7(2): 135 - 140. [Abstract] [PDF]
|
|
|
|
 |
|
 P Menasche and M Desnos Cardiac reparation: fixing the heart with cells, new vessels and genes Eur. Heart J. Suppl., April 1, 2002; 4(suppl_D): D73 - D81. [Abstract] [PDF]
|
|
|
|
|
|
B. Pouzet, S. Ghostine, J.-T. Vilquin, I. Garcin, M. Scorsin, A. A. Hagege, D. Duboc, K. Schwartz, and P. Menasche Is Skeletal Myoblast Transplantation Clinically Relevant in the Era of Angiotensin-Converting Enzyme Inhibitors? Circulation, September 18, 2001; 104(90001): I-223 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Rajnoch, J.-C. Chachques, A. Berrebi, P. Bruneval, M.-O. Benoit, and A. Carpentier Cellular therapy reverses myocardial dysfunction J. Thorac. Cardiovasc. Surg., May 1, 2001; 121(5): 871 - 878. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. El Oakley, O. C. Ooi, A. Bongso, and M. H. Yacoub Myocyte transplantation for myocardial repair: a few good cells can mend a broken heart Ann. Thorac. Surg., May 1, 2001; 71(5): 1724 - 1733. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
